Abstract
A boy with X-linked agammaglobulinemia experienced progressive global motor decline, cerebellar syndrome, and epilepsy. All standard polymerase chain reactions for neurotropic viruses were negative on cerebrospinal fluid and brain biopsy. Next-generation sequencing allowed fast identification of a new astrovirus strain (HAstV-VA1/HMO-C-PA), which led to tailor the patient's treatment, with encouraging clinical monitoring over 1 year.
Keywords:
Bruton; agammaglobulinemia; astrovirus; encephalitis.
© The Author 2015. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Agammaglobulinemia / complications*
-
Agammaglobulinemia / drug therapy
-
Anti-Inflammatory Agents / therapeutic use
-
Antiviral Agents / administration & dosage
-
Antiviral Agents / therapeutic use
-
Astroviridae / classification
-
Astroviridae / genetics*
-
Astroviridae / isolation & purification
-
Astroviridae Infections / diagnosis
-
Astroviridae Infections / drug therapy*
-
Astroviridae Infections / virology*
-
Cerebellar Diseases / drug therapy
-
Cerebellar Diseases / etiology
-
Encephalitis, Viral / diagnosis
-
Encephalitis, Viral / drug therapy*
-
Encephalitis, Viral / virology*
-
Epilepsy / drug therapy
-
Epilepsy / etiology
-
Genetic Diseases, X-Linked / complications*
-
Genetic Diseases, X-Linked / drug therapy
-
Genome, Viral
-
High-Throughput Nucleotide Sequencing
-
Humans
-
Male
-
Sequence Analysis, RNA
Substances
-
Anti-Inflammatory Agents
-
Antiviral Agents
Supplementary concepts
-
Bruton type agammaglobulinemia